Prioritizing de novo potential non-canonical splicing variants in neurodevelopmental disorders

[1]  K. Xia,et al.  Performance evaluation of differential splicing analysis methods and splicing analytics platform construction , 2022, Nucleic acids research.

[2]  E. Eichler,et al.  GIGYF1 disruption associates with autism and impaired IGF-1R signaling , 2022, The Journal of clinical investigation.

[3]  D. Baralle,et al.  A systematic analysis of splicing variants identifies new diagnoses in the 100,000 Genomes Project , 2022, Genome Medicine.

[4]  Vicente A. Yépez,et al.  Aberrant splicing prediction across human tissues , 2022, bioRxiv.

[5]  Zhongsheng Sun,et al.  Integrative analysis prioritised oxytocin-related biomarkers associated with the aetiology of autism spectrum disorder , 2022, EBioMedicine.

[6]  Sicong Zeng,et al.  RNA splicing analysis contributes to reclassifying variants of uncertain significance and improves the diagnosis of monogenic disorders , 2022, Journal of Medical Genetics.

[7]  D. Baralle,et al.  A systematic analysis of splicing variants identifies new diagnoses in the 100,000 Genomes Project , 2022, medRxiv.

[8]  Robert J. Weatheritt,et al.  Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants. , 2021, Genetics in medicine : official journal of the American College of Medical Genetics.

[9]  Hsin-Nan Lin,et al.  Mechanism and modeling of human disease-associated near-exon intronic variants that perturb RNA splicing , 2021, Nature Structural & Molecular Biology.

[10]  Y. Bromberg,et al.  Decoding the effects of synonymous variants , 2021, bioRxiv.

[11]  D. Baralle,et al.  Splicing in the Diagnosis of Rare Disease: Advances and Challenges , 2021, Frontiers in Genetics.

[12]  B. Greenberg,et al.  Exome sequencing in obsessive–compulsive disorder reveals a burden of rare damaging coding variants , 2021, Nature Neuroscience.

[13]  N. Matoba,et al.  Systematic analysis of exonic germline and postzygotic de novo mutations in bipolar disorder , 2021, Nature Communications.

[14]  Chunyu Liu,et al.  Cross-Disorder Analysis of De Novo Mutations in Neuropsychiatric Disorders , 2021, Journal of Autism and Developmental Disorders.

[15]  R. Nussbaum,et al.  Spectrum of splicing variants in disease genes and the ability of RNA analysis to reduce uncertainty in clinical interpretation , 2021, American journal of human genetics.

[16]  R. Person,et al.  CACNA1I gain-of-function mutations differentially affect channel gating and cause neurodevelopmental disorders , 2021, Brain : a journal of neurology.

[17]  Michael H. Guo,et al.  High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiency , 2021, medRxiv.

[18]  Xiaoming Liu,et al.  dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs , 2020, Genome Medicine.

[19]  C. Lelliott,et al.  Heterozygous Variants in KDM4B Lead to Global Developmental Delay and Neuroanatomical Defects. , 2020, American journal of human genetics.

[20]  N. Brown,et al.  NCKAP1 Disruptive Variants Lead to a Neurodevelopmental Disorder with Core Features of Autism. , 2020, American journal of human genetics.

[21]  Richard A Marini,et al.  Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders , 2020, Nature Communications.

[22]  Patrick J. Short,et al.  Evidence for 28 genetic disorders discovered by combining healthcare and research data , 2020, Nature.

[23]  C. Cytrynbaum,et al.  De Novo Variants in the ATPase Module of MORC2 Cause a Neurodevelopmental Disorder with Growth Retardation and Variable Craniofacial Dysmorphism. , 2020, American journal of human genetics.

[24]  D. Baralle,et al.  Blood RNA analysis can increase clinical diagnostic rate and resolve variants of uncertain significance , 2020, Genetics in Medicine.

[25]  M. Daly,et al.  Exome sequencing in schizophrenia-affected parent-offspring trios reveals risk conferred by protein-coding de novo mutations , 2019, Nature Neuroscience.

[26]  Michael T. Eadon,et al.  RegSNPs-intron: a computational framework for predicting pathogenic impact of intronic single nucleotide variants , 2019, Genome Biology.

[27]  Z. Wang,et al.  Gene4Denovo: an integrated database and analytic platform for de novo mutations in humans , 2019, Nucleic Acids Res..

[28]  Laura Pérez-Cano,et al.  Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks , 2019, Cell.

[29]  Emily K. Mis,et al.  Novel truncating mutations in CTNND1 cause a dominant craniofacial and cardiac syndrome , 2019, bioRxiv.

[30]  N. Zhang,et al.  Nonrandom occurrence of multiple de novo coding variants in a proband indicates the existence of an oligogenic model in autism , 2019, Genetics in Medicine.

[31]  Jen Q. Pan,et al.  Predicting functional effects of missense variants in voltage-gated sodium and calcium channels , 2019, Science Translational Medicine.

[32]  Matthew W. Mosconi,et al.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism , 2019, Cell.

[33]  Meghan T. Miller,et al.  Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder , 2019, Brain : a journal of neurology.

[34]  David G. Knowles,et al.  Predicting Splicing from Primary Sequence with Deep Learning , 2019, Cell.

[35]  E. M. Jones,et al.  A Multiplexed Assay for Exon Recognition Reveals that an Unappreciated Fraction of Rare Genetic Variants Cause Large-Effect Splicing Disruptions. , 2019, Molecular cell.

[36]  Ryan L. Collins,et al.  Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder , 2018, Science.

[37]  Jeffrey D. Mandell,et al.  De Novo Sequence and Copy Number Variants Are Strongly Associated with Tourette Disorder and Implicate Cell Polarity in Pathogenesis. , 2018, Cell reports.

[38]  Trygve E Bakken,et al.  Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity , 2018, Nature Genetics.

[39]  A. Spurdle,et al.  Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort , 2018, Nucleic Acids Research.

[40]  Patrick J. Short,et al.  Pathogenicity and selective constraint on variation near splice sites , 2018, bioRxiv.

[41]  Yi Zhang,et al.  Performance evaluation of pathogenicity-computation methods for missense variants , 2018, Nucleic acids research.

[42]  Scott I. Adamson,et al.  Vex-seq: high-throughput identification of the impact of genetic variation on pre-mRNA splicing efficiency , 2018, Genome Biology.

[43]  David Haussler,et al.  Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis , 2018, Cell.

[44]  A. Spurdle,et al.  Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort , 2018, Nucleic acids research.

[45]  Bradley P. Coe,et al.  Recurrent de novo mutations in neurodevelopmental disorders: properties and clinical implications , 2017, Genome Medicine.

[46]  M. Rivas,et al.  Base-specific mutational intolerance near splice sites clarifies the role of nonessential splice nucleotides , 2017, bioRxiv.

[47]  Kamil J. Cygan,et al.  Pathogenic variants that alter protein code often disrupt splicing , 2017, Nature Genetics.

[48]  B. Frey,et al.  Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder , 2017, Nature Neuroscience.

[49]  S. Mccarroll,et al.  Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1–PAK3 signaling in neuroplasticity , 2017, Molecular Psychiatry.

[50]  Xin Gao,et al.  A new mode of SAM domain mediated oligomerization observed in the CASKIN2 neuronal scaffolding protein , 2016, Cell Communication and Signaling.

[51]  C. Shaw,et al.  De Novo Truncating Mutation of TRIM8 Causes Early‐Onset Epileptic Encephalopathy , 2016, Annals of human genetics.

[52]  Christian Gilissen,et al.  ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation , 2016, Nature Communications.

[53]  Iuliana Ionita-Laza,et al.  De Novo Synonymous Mutations in Regulatory Elements Contribute to the Genetic Etiology of Autism and Schizophrenia , 2016, Neuron.

[54]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[55]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[56]  Eric Boerwinkle,et al.  In silico prediction of splice-altering single nucleotide variants in the human genome , 2014, Nucleic acids research.

[57]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.

[58]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[59]  Sharmila Banerjee-Basu,et al.  SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs) , 2013, Molecular Autism.

[60]  C. Pozniak,et al.  JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis , 2013, The Journal of cell biology.

[61]  Michael R. Johnson,et al.  De novo mutations in the classic epileptic encephalopathies , 2013, Nature.

[62]  N. Simonis,et al.  FGFR1 mutations cause Hartsfield syndrome, the unique association of holoprosencephaly and ectrodactyly , 2013, Journal of Medical Genetics.

[63]  B. V. van Bon,et al.  Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.

[64]  T. Cooper.  Use of minigene systems to dissect alternative splicing elements. , 2005, Methods.

[65]  R. Guigó,et al.  Are splicing mutations the most frequent cause of hereditary disease? , 2005, FEBS letters.

[66]  M. Patton,et al.  Floating-Harbor syndrome: description of a further patient, review of the literature, and suggestion of autosomal dominant inheritance , 1995, European Journal of Pediatrics.

[67]  E. Guest.  Effort , 1924, Definitions.

[68]  De novo mutations in epileptic encephalopathies , 2013 .